CVS Health Gets a Hold Rating from Jefferies

By Ryan Adsit

Jefferies analyst David Steinberg assigned a Hold rating to CVS Health (NYSE: CVS) today and set a price target of $86. The company’s shares opened today at $82.21.

According to TipRanks.com, Steinberg is a 4-star analyst with an average return of 7.3% and a 48.5% success rate. Steinberg covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Spectrum Pharmaceuticals, and Supernus Pharmaceuticals.

Currently, the analyst consensus on CVS Health is Moderate Buy and the average price target is $86.17, representing a 4.8% upside.

In a report issued on September 8, Needham also reiterated a Hold rating on the stock.

The company has a one year high of $90.85 and a one year low of $69.30. Currently, CVS Health has an average volume of 5.44M.

Based on the recent corporate insider activity of 71 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise.